To determine the role of BRAF in the pathogenesis of AML, we first explored the BRAF expression in our RNA-seq analysis including bone marrow sample from patients with MDS, AML and secondary AML (sAML) which arises from previous MDS. Here, BRAF is linked to myelodysplastic syndrome.